• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

正常人血清对流感病毒的中和作用:涉及抗体和补体的机制。

Neutralization of influenza virus by normal human sera: mechanisms involving antibody and complement.

作者信息

Beebe D P, Schreiber R D, Cooper N R

出版信息

J Immunol. 1983 Mar;130(3):1317-22.

PMID:6822737
Abstract

All normal human sera examined neutralized WS/33 H1N1 influenza virus efficiently by one of two antibody-dependent mechanisms. A minority of the sera contained moderate levels of IgG antibody directed against the viral hemagglutinin that had the ability to directly neutralize the virus. The majority of sera tested contained very low levels of IgG anti-hemagglutinin antibody, which was detectable with a specific ELISA but not by conventional HAI assays. Such IgG antibody was unable to directly neutralize the virus. Studies with agammaglobulinemic serum and with sera depleted of and reconstituted with complement components established essential roles for IgG and the components of the classical complement pathway through C3 for neutralization. The components of the alternative and membrane attack pathways were not needed for neutralization. As anticipated from the requirement for IgG and exclusive mediation of neutralization by the classical pathway, the virus-IgG immune complex activated purified C1. Binding of C3 and C4 to the virus was demonstrated, as was classical pathway-mediated triggering of the alternative pathway, with recruitment of properdin. In addition, the H1N1 influenza virus also directly activated the alternative complement pathway in human serum, leading to C3 and properdin deposition on the viral envelope. Such direct alternative pathway activation also required immunoglobulin. However, the alternative pathway alone was unable to neutralize the virus. Thus, most normal sera examined contain low levels of IgG anti-hemagglutinin antibody, which activate the classical pathway of the complement system and neutralize WS/33 influenza virus by deposition of C3 and C4 on the viral envelope.

摘要

所有检测的正常人血清通过两种抗体依赖性机制之一有效地中和了WS/33 H1N1流感病毒。少数血清含有中等水平的针对病毒血凝素的IgG抗体,该抗体具有直接中和病毒的能力。大多数检测的血清含有极低水平的IgG抗血凝素抗体,这种抗体可用特异性ELISA检测到,但用传统的血凝抑制(HAI)试验检测不到。这种IgG抗体无法直接中和病毒。对无丙种球蛋白血症血清以及去除和重新补充补体成分的血清进行的研究确定了IgG和经典补体途径中通过C3的成分在中和作用中的重要作用。替代途径和膜攻击途径的成分对于中和作用不是必需的。正如从对IgG的需求以及经典途径对中和作用的排他性介导所预期的那样,病毒-IgG免疫复合物激活了纯化的C1。证明了C3和C4与病毒的结合,以及经典途径介导的替代途径的触发,伴有备解素的募集。此外,H1N1流感病毒还直接激活人血清中的替代补体途径,导致C3和备解素沉积在病毒包膜上。这种直接的替代途径激活也需要免疫球蛋白。然而,仅替代途径无法中和病毒。因此,大多数检测的正常血清含有低水平的IgG抗血凝素抗体,这些抗体激活补体系统的经典途径,并通过C3和C4沉积在病毒包膜上来中和WS/33流感病毒。

相似文献

1
Neutralization of influenza virus by normal human sera: mechanisms involving antibody and complement.正常人血清对流感病毒的中和作用:涉及抗体和补体的机制。
J Immunol. 1983 Mar;130(3):1317-22.
2
Neutralization of vesicular stomatitis virus (VSV) by human complement requires a natural IgM antibody present in human serum.人补体对水疱性口炎病毒(VSV)的中和作用需要人血清中存在的天然IgM抗体。
J Immunol. 1981 Apr;126(4):1562-8.
3
Activation of the alternative complement pathway by EBV and the viral envelope glycoprotein, gp350.EBV和病毒包膜糖蛋白gp350对替代补体途径的激活。
J Immunol. 1988 Jun 1;140(11):3867-74.
4
Effect of selective complement deficiency on the rate of neutralization of enveloped viruses by human sera.选择性补体缺乏对人血清中和包膜病毒速率的影响。
J Immunol. 1977 Jan;118(1):28-34.
5
Interactions of a nonneutralizing IgM antibody and complement in parainfluenza virus neutralization.副流感病毒中和过程中一种非中和性IgM抗体与补体的相互作用。
Virology. 1988 Dec;167(2):433-41.
6
Neutralization of Epstein-Barr virus by nonimmune human serum. Role of cross-reacting antibody to herpes simplex virus and complement.非免疫人血清对爱泼斯坦-巴尔病毒的中和作用。抗单纯疱疹病毒交叉反应抗体和补体的作用。
J Clin Invest. 1982 Nov;70(5):1081-91. doi: 10.1172/jci110696.
7
Antibody-independent neutralization of vesicular stomatitis virus by human complement. II. Formation of VSV-lipoprotein complexes in human serum and complement-dependent viral lysis.人补体对水疱性口炎病毒的非抗体依赖性中和作用。II. 人血清中VSV-脂蛋白复合物的形成及补体依赖性病毒裂解
J Immunol. 1979 Dec;123(6):2518-24.
8
Inhibition of C3 deposition on solid-phase bound immune complexes by lactoferrin.乳铁蛋白对固相结合免疫复合物上C3沉积的抑制作用。
Immunology. 1985 Mar;54(3):449-56.
9
Possible mechanisms of the first step of the classical complement activation pathway: binding and activation of C1.经典补体激活途径第一步的可能机制:C1的结合与激活。
Immunology. 1978 Dec;35(6):873-84.
10
Depressed classical complement pathway activities in chronic lymphocytic leukaemia.慢性淋巴细胞白血病中经典补体途径活性降低。
Clin Exp Immunol. 1985 Jun;60(3):489-95.

引用本文的文献

1
Molecular Mechanisms Underlying Response to Influenza in Grey Seals (Halichoerus grypus), a Potential Wild Reservoir.灰海豹(Halichoerus grypus)作为潜在野生宿主对流感反应的分子机制,灰海豹是一种潜在的野生宿主。
Mol Ecol. 2025 Aug;34(15):e70012. doi: 10.1111/mec.70012. Epub 2025 Jul 4.
2
Complement-mediated enhancement of SARS-CoV-2 antibody neutralisation potency in vaccinated individuals.补体介导的接种个体中SARS-CoV-2抗体中和效力增强
Nat Commun. 2025 Mar 18;16(1):2666. doi: 10.1038/s41467-025-57947-8.
3
Mapping the interaction sites of human and avian influenza A viruses and complement factor H.
绘制甲型人流感病毒和禽流感病毒与补体因子H的相互作用位点
Front Immunol. 2024 Apr 18;15:1352022. doi: 10.3389/fimmu.2024.1352022. eCollection 2024.
4
Direct enhancement of viral neutralising antibody potency by the complement system: a largely forgotten phenomenon.补体系统直接增强病毒中和抗体效力:一个被广泛遗忘的现象。
Cell Mol Life Sci. 2024 Jan 11;81(1):22. doi: 10.1007/s00018-023-05074-2.
5
Antibody Responsiveness to Influenza: What Drives It?流感抗体反应:是什么驱动了它?
Viruses. 2021 Jul 19;13(7):1400. doi: 10.3390/v13071400.
6
Sex-specific differences of humoral immunity and transcriptome diversification in older adults vaccinated with inactivated quadrivalent influenza vaccines.接种四价流感灭活疫苗的老年人体液免疫和转录组多样性的性别差异
Aging (Albany NY). 2021 Mar 19;13(7):9801-9819. doi: 10.18632/aging.202733.
7
Immunoglobulin M in Health and Diseases: How Far Have We Come and What Next?免疫球蛋白 M 在健康与疾病中的作用:我们已经走了多远,下一步该如何?
Front Immunol. 2020 Oct 30;11:595535. doi: 10.3389/fimmu.2020.595535. eCollection 2020.
8
In the Crosshairs: RNA Viruses OR Complement?在瞄准镜中:RNA 病毒还是补体?
Front Immunol. 2020 Sep 29;11:573583. doi: 10.3389/fimmu.2020.573583. eCollection 2020.
9
Non-neutralizing Antibodies Directed at Conservative Influenza Antigens.针对保守流感抗原的非中和抗体。
Acta Naturae. 2019 Oct-Dec;11(4):22-32. doi: 10.32607/20758251-2019-11-4-22-32.
10
Glycan Reactive Natural Antibodies and Viral Immunity.糖基反应性天然抗体与病毒免疫。
Viral Immunol. 2020 May;33(4):266-276. doi: 10.1089/vim.2019.0136. Epub 2019 Dec 17.